Hyperglycemia induces microglial pyroptosis via activation of NLRP3 inflammasome: implication in neurological impairment during ischemia stroke

Ensi Luo,Zhuo Li,Shiying Zhang,Yin Wen,Zhiyong Yang,Xusheng Liu,Weifeng Liu,Hongke Zeng,Hongguang Ding
DOI: https://doi.org/10.21203/rs.3.rs-2807085/v1
2023-01-01
Abstract:Elevated levels of blood glucose in patients with ischemic stroke are associated with a worse prognosis. This study aimed to explore whether hyperglycemia promotes microglial pyroptosis via activating NLRP3 inflammasome in an acute ischemic stroke model. C57BL/6 mice that underwent middle cerebral artery occlusion were used for assessment of blood glucose level and neurological function. To investigate the significance of NLRP3 inflammasome, the NLRP3 −/− mice were applied and the expression levels of NLRP3, caspase-1, GSDMS-D, IL-1β and IL-18 were evaluated. In addition, Z-YVAD-FMK, a caspase-1 inhibitor, was used to treat microglia to determine whether activation of NLRP3 inflammasome was required for the enhancing effect of hyperglycemia on pyroptosis. We revealed that hyperglycemia accelerated cerebral injury in the acute ischemic stroke model, evidenced by decreased latencies to falls and percentage of foot fault. Furthermore, hyperglycemia induced microglial pyroptosis, proved by the evidence of increased levels of caspase-1, GSDMS-N, IL-1β and IL-18. However, the knockout of NLRP3 attenuated these effects. Pharmacological inhibition of caspase-1 also reduced the expression levels of GSDMS-N, IL-1β and IL-18 in microglial cells. These results suggested that hyperglycemia stimulated NLRP3 inflammasome activation and caspase-1 expression up-regulation, thus leading to the aggravation of pyroptosis following ischemic stroke.
What problem does this paper attempt to address?